Critical role for sphingosine kinase-1 in regulating survival of neuroblastoma cells exposed to amyloid-β peptide

Molecular Pharmacology

Volumn 72, Issue 2, 2007, Pages 341-349

  Gomez Brouchet, Anne ^a,b,c   Pchejetski, Dimitri ^a,b,d   Brizuela, Leyre ^b,d   Garcia, Virginie ^a,b   Altié, Marie Françoise ^a,b   Maddelein, Marie Lise ^b,d   Delisle, Marie Bernadette ^a,b,c   Cuvillier, Olivier ^a,b,d  

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 HYDROXYANILINO) 4 (4 CHLOROPHENYL)THIAZOLE; ACETYLCYSTEINE; AMYLOID BETA PROTEIN; CERAMIDE; SOMATOMEDIN C; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1; THIAZOLE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROPROTECTION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

AMYLOID BETA-PROTEIN; CELL LINE; CELL SURVIVAL; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NEUROBLASTOMA; PEPTIDE FRAGMENTS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); TRANSFORMING GROWTH FACTOR BETA1;

EID: 34547182992     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.033738     Document Type: Article

References (52)

1. Abe A, Shayman JA, and Radin NS (1996) A novel enzyme that catalyzes the esterification of N-acetylsphingosine. J Biol Chem 271:14383-14389.
2. Alessenko AV, Bugrova AE, and Dudnik LB (2004) Connection of lipid peroxide oxidation with the sphingomyelin pathway in the development of Alzheimer's disease. Biochem Soc Trans 32:144-146.
3. Arias E, Gallego-Sandin S, Villarroya M, Garcia AG, and Lopez MG (2005) Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. J Pharmacol Exp Ther 315:1346-1353.
4. Ayasolla K, Khan M, Singh AK, and Singh I (2004) Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E. Free Radic Biol Med 37:325-338.
5. Bonhoure E, Pchejetski D, Aouali N, Morjani H, Levade T, Kohama T, and Cuvillier O (2006) Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1. Leukemia 20:95-102.
6. Carro E and Torres-Aleman I (2004) The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease. Eur J Pharmacol 490:127-133.
7. Carro E, Trejo JL, Gomez-Isla T, LeRoith D, and Torres-Aleman I (2002) Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med 8:1390-1397.
8. Chao CC, Hu S, Kravitz FH, Tsang M, Anderson WR, and Peterson PK (1994) Transforming growth factor-beta protects human neurons against beta-amyloid-induced injury. Mol Chem Neuropathol 23:159-178.
9. Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, and Mattson MP (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci U S A 101:2070-2075.
10. Cuvillier O and Levade T (2001) Sphingosine 1-phosphate antagonizes apoptosis of human leukemia cells by inhibiting release of cytochrome c and Smac/DIABLO from mitochondria. Blood 98:2828-2836.
11. Cuvillier O, Mayhew E, Janoff AS, and Spiegel S (1999) Liposomal ET-18-OCH(3) induces cytochrome c-mediated apoptosis independently of CD95 (APO-1/Fas) signaling. Blood 94:3583-3592.
12. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S, and Spiegel S (1996) Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381:800-803.
13. Datki Z, Juhasz A, Galfi M, Soos K, Papp R, Zadori D, and Penke B (2003) Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells. Brain Res Bull 62:223-229.
14. De Servi B, La Porta CA, Bontempelli M, and Comolli R (2002) Decrease of TGF-beta1 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's disease. Exp Gerontol 37:813-821.
15. Doré S, Kar S, and Quirion R (1997) Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proc Natl Acad Sci U S A 94:4772-4777.
16. Edsall L, Vann L, Milstien S, and Spiegel S (2000) Enzymatic method for measurement of sphingosine 1-phosphate. Methods Enzymol 312:9-16.
17. Edsall LC, Cuvillier O, Twitty S, Spiegel S, and Milstien S (2001) Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells. J Neurochem 76:1573-1584.
18. Flanders KC, Ren RF, and Lippa CF (1998) Transforming growth factor-betas in neurodegenerative disease. Prog Neurobiol 54:71-85.
19. French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN, Eberly JL, Yun JK, and Smith CD (2003) Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 63:5962-5969.
20. Han X, D MH, McKeel DW, Jr., Kelley J, and Morris JC (2002) Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J Neurochem 82:809-818.
21. Hannun YA and Obeid LM (2002) The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem 277:25847-25850.
22. Jana A and Pahan K (2004) Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease. J Biol Chem 279:51451-51459.
23. Lee JT, Xu J, Lee JM, Ku G, Han X, Yang DI, Chen S, and Hsu CY (2004) Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J Cell Biol 164:123-131.
24. Li YP, Bushnell AF, Lee CM, Perlmutter LS, and Wong SK (1996) Beta-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells. Brain Res 738:196-204.
25. Luetjens CM, Lankiewicz S, Bui NT, Krohn AJ, Poppe M, and Prehn JH (2001) Up-regulation of Bcl-xL in response to subtoxic beta-amyloid: role in neuronal resistance against apoptotic and oxidative injury. Neuroscience 102:139-150.
26. Maceyka M, Sankala H, Hait NC, Le Stunff H, Liu H, Toman R, Collier C, Zhang M, Satin LS, Merrill AH, et al. (2005) SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J Biol Chem 280:37118-37129.
27. Müller WE, Romero FJ, Perovic S, Pergande G, and Pialoglou P (1997) Protection of flupirtine on beta-amyloid-induced apoptosis in neuronal cells in vitro: prevention of amyloid-induced glutathione depletion. J Neurochem 68:2371-2377.
28. Nava VE, Cuvillier O, Edsall LC, Kimura K, Milstien S, Gelmann EP, and Spiegel S (2000) Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells. Cancer Res 60:4468-4474.
29. Nava VE, Hobson JP, Murthy S, Milstien S, and Spiegel S (2002) Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Experimental cell research 281:115-127.
30. Niikura T, Hashimoto Y, Okamoto T, Abe Y, Yasukawa T, Kawasumi M, Hiraki T, Kita Y, Terashita K, Kouyama K, et al. (2001) Insulin-like growth factor I (IGF-I) protects cells from apoptosis by Alzheimer's V642I mutant amyloid precursor protein through IGF-I receptor in an IGF-binding protein-sensitive manner. J Neurosci 21:1902-1910.
31. Olivera A, Kohama T, Edsall L, Nava V, Cuvillier O, Poulton S, and Spiegel S (1999) Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J Cell Biol 147:545-558.
32. Olivieri G, Baysang G, Meier F, Muller-Spahn F, Stahelin HB, Brockhaus M, and Brack C (2001) N-acetyl-L-cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: effects on beta-amyloid secretion and tau phosphorylation. J Neurochem 76:224-233.
33. Pchejetski D, Golzio M, Bonhoure E, Calvet C, Doumerc N, Garcia V, Mazerolles C, Rischmann P, Teissie J, Malavaud B, et al. (2005) Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Res 65:11667-11675.
34. Pchejetski D, Kunduzova O, Dayon A, Calise D, Seguelas MH, Leducq N, Seif I, Parini A, and Cuvillier O (2007) Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis. Circ Res 100:41-49.
35. Pereira C, Santos MS, and Oliveira C (1999) Involvement of oxidative stress on the impairment of energy metabolism induced by A beta peptides on PC12 cells: protection by antioxidants. Neurobiol Dis 6:209-219.
36. Pettifer KM, Kleywegt S, Bau CJ, Ramsbottom JD, Vertes E, Ciccarelli R, Caciagli F, Werstiuk ES, and Rathbone MP (2004) Guanosine protects SH-SY5Y cells against beta-amyloid-induced apoptosis. Neuroreport 15:833-836.
37. Pitson SM, Moretti PA, Zebol JR, Xia P, Gamble JR, Vadas MA, D'Andrea RJ, and Wattenberg BW (2000) Expression of a catalytically inactive sphingosine kinase mutant blocks agonist-induced sphingosine kinase activation. A dominant-negative sphingosine kinase. J Biol Chem 275:33945-33950.
38. Prehn JH, Bindokas VP, Jordan J, Galindo MF, Ghadge GD, Roos RP, Boise LH, Thompson CB, Krajewski S, Reed JC, et al. (1996) Protective effect of transforming growth factor-β1 on β-amyloid neurotoxicity in rat hippocampal neurons. Mol Pharmacol 49:319-328.
39. Ren RF and Flanders KC (1996) Transforming growth factors-beta protect primary rat hippocampal neuronal cultures from degeneration induced by beta-amyloid peptide. Brain Res 732:16-24.
40. Ren RF, Hawver DB, Kim RS, and Flanders KC (1997) Transforming growth factor-beta protects human hNT cells from degeneration induced by beta-amyloid peptide: involvement of the TGF-beta type II receptor. Brain Res Mol Brain Res 48:315-322.
41. Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Gowing E, and Ball MJ (1993) beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc Natl Acad Sci U S A 90:10836-10840.
42. Satoi H, Tomimoto H, Ohtani R, Kitano T, Kondo T, Watanabe M, Oka N, Akiguchi I, Furuya S, Hirabayashi Y, et al. (2005) Astroglial expression of ceramide in Alzheimer's disease brains: a role during neuronal apoptosis. Neuroscience 130:657-666.
43. Selkoe DJ (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81:741-766.
44. Spiegel S and Milstien S (2003) Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4:397-407.
45. Taha TA, Kitatani K, El-Alwani M, Bielawski J, Hannun YA, and Obeid LM (2006) Loss of sphingosine kinase-1 activates the intrinsic pathway of programmed cell death: modulation of sphingolipid levels and the induction of apoptosis. FASEB J 20:482-484.
46. Taha TA, Osta W, Kozhaya L, Bielawski J, Johnson KR, Gillanders WE, Dbaibo GS, Hannun YA, and Obeid LM (2004) Down-regulation of sphingosine kinase-1 by DNA damage: dependence on proteases and p53. J Biol Chem 279:20546-20554.
47. Tesseur I, Zou K, Esposito L, Bard F, Berber E, Can JV, Lin AH, Crews L, Tremblay P, Mathews P, et al. (2006) Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology. J Clin Invest 116:3060-3069.
48. Uberti D, Rizzini C, Spano PF, and Memo M (1997) Characterization of tau proteins in human neuroblastoma SH-SY5Y cell line. Neurosci Lett 235:149-153.
49. Wei W, Wang X, and Kusiak JW (2002) Signaling events in amyloid β-peptide-induced neuronal death and insulin-like growth factor I protection. J Biol Chem 277:17649-17656.
50. Yamanaka M, Shegogue D, Pei H, Bu S, Bielawska A, Bielawski J, Pettus B, Hannun YA, Obeid L, and Trojanowska M (2004) Sphingosine kinase 1 (SPHK1) is induced by transforming growth factor-β and mediates TIMP-1 up-regulation. J Biol Chem 279:53994-54001.
51. Yang DI, Yeh CH, Chen S, Xu J, and Hsu CY (2004) Neutral sphingomyelinase activation in endothelial and glial cell death induced by amyloid beta-peptide. Neurobiol Dis 17:99-107.
52. Zeng C, Lee JT, Chen H, Chen S, Hsu CY, and Xu J (2005) Amyloid-beta peptide enhances tumor necrosis factor-alpha-induced iNOS through neutral sphingomyelinase/ ceramide pathway in oligodendrocytes. J Neurochem 94:703-712.